Bvf Inc Albireo Pharma, Inc. Transaction History

Bvf Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.92 - $28.96 $490,680 - $839,840	-29,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $730,000 - $1.16 Million	-36,500 Reduced 55.73%	29,000 $580,000
Q2 2019 Aug 14, 2019	SELL	$30.67 - $37.86 $4.14 Million - $5.11 Million	-135,000 Reduced 67.33%	65,500 $2.11 Million
Q4 2018 Feb 14, 2019	SELL	$20.9 - $32.57 $382,470 - $596,031	-18,300 Reduced 8.36%	200,500 $4.92 Million
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $35,148 - $44,244	-1,200 Reduced 0.55%	218,800 $7.21 Million
Q2 2018 Aug 14, 2018	SELL	$28.9 - $37.31 $144,500 - $186,550	-5,000 Reduced 2.22%	220,000 $7.81 Million
Q1 2018 May 07, 2018	BUY	$26.78 - $39.35 $6.03 Million - $8.85 Million	225,000 New	225,000 $7.33 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.